INNT stock forecast
Our latest prediction for Innovate Biopharmaceuticals, Inc.'s stock price was made on the Jan. 26, 2018 when the stock price was at 5.76$.
In the short term (2weeks), INNT's stock price should outperform the market by 3.60%. During that period the price should oscillate between -10.55% and +21.16%.
In the medium term (3months), INNT's stock price should underperform the market by -2.66%. During that period the price should oscillate between -25.33% and +63.61%.Get email alerts
Create a solid portfolio with INNT
About Innovate Biopharmaceuticals, Inc.
Innovate Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.44$ per share.
The book value per share is 0.13$
Three months stock forecastJan. 26, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|